Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide

Clinical and Experimental Nephrology

Volumn 11, Issue 4, 2007, Pages 297-303

  Mitsuiki, Koji ^a   Harada, Atsumi ^a   Okura, Takafumi ^b   Higaki, Jitsuo ^b  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclophosphamide; IgA nephropathy; Prednisolone; Renal survival

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN A; INSULIN; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH ULCER; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TISSUE SECTION; TREATMENT RESPONSE;

ADULT; CREATININE; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDNISOLONE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 37249021550     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-007-0497-0     Document Type: Article

References (31)

1. G D'Amico 1987 The commonest glomerulonephritis in the world: IgA nephropathy Q J Med 64 709 27
2. P Stratta GP Segoloni C Canavese L Sandri G Mazzucco D Roccatello 1996 Incidence of biopsy-proven primary glomerulonephritis in an Italian province Am J Kidney Dis 27 631 9
3. JH Galla 1995 IgA nephropathy Kidney Int 47 377 87
4. A Koyama M Igarashi M Kobayashi 1997 Natural history and risk factors for immunoglobulin A nephropathy in Japan Am J Kidney Dis 29 526 32
5. E Alamartine JC Sabatier C Guerin JM Berliet F Berthoux 1991 Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses Am J Kidney Dis 18 12 9
6. LS Ibels AZ Gyory 1994 IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature Medicine 73 79 102
7. GF Strippoli C Manno FP Schena 2003 An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism Am J Kidney Dis 41 1129 39
8. J Floege F Eitner 2005 Present and future therapy options in IgA-nephropathy J Nephrol 18 354 61
9. F Locatelli L Del Vecchio C Pozzi 2006 IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors Nat Clin Pract Nephrol 2 24 31
10. J Barratt J Feehally 2006 Treatment of IgA nephropathy Kidney Int 69 1934 8
11. GB Appel M Waldman 2006 The IgA nephropathy treatment dilemma Kidney Int 69 1939 44
12. R Katafuchi K Ikeda T Mizumasa H Tanaka T Ando T Yanase 2003 Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy Am J Kidney Dis 41 972 83
13. Y Kobayashi Y Hiki K Fujii A Kurokawa S Tateno 1989 Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases Nephron 53 250 6
14. O Hotta M Miyazaki T Furuta S Tomioka S Chiba I Horigome 2001 Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy Am J Kidney Dis 38 736 43
15. S Tamura K Ueki H Ideura Y Tsukada A Maezawa H Kawai 2001 Corticosteroid therapy in patients with IgA nephropathy and impaired renal function Clin Nephrol 55 192 5
16. M Sato O Hotta S Tomioka I Horigome S Chiba M Miyazaki 2003 Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy Nephron Clin Pract 93 c137 45
17. C Pozzi S Andrulli L Del Vecchio P Melis GB Fogazzi P Altieri 2004 Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial J Am Soc Nephrol 15 157 63
18. K Tsuruya A Harada H Hirakata K Mitsuiki T Johko H Kondoh 2000 Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy Clin Nephrol 53 1 9
19. CW McIntyre RJ Fluck SH Lambie 2001 Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment Clin Nephrol 56 193 8
20. FW Ballardie IS Roberts 2002 Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy J Am Soc Nephrol 13 142 8
21. JA Tumlin V Lohavichan R Hennigar 2003 Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide Nephrol Dial Transplant 18 1321 9
22. FM Rasche CH Klotz D Czock W Karges R Muche PM Jehle 2003 Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy Nephron Clin Pract 93 c131 6
23. N Yoshikawa H Ito T Sakai Y Takekoshi M Honda M Awazu 1999 A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group J Am Soc Nephrol 10 101 9
24. DS Goumenos P Davlouros AM El Nahas M Ahuja JR Shortland JG Vlachojannis 2003 Prednisolone and azathioprine in IgA nephropathy - a 10-year follow-up study Nephron Clin Pract 93 c58 68
25. X Chen P Chen G Cai J Wu Y Cui Y Zhang 2002 A randomized control trial of mycophenolate mofetil treatment in severe IgA nephropathy (in Chinese) Zhonghua Yi Xue Za Zhi 82 796 801
26. BD Maes R Oyen K Claes P Evenepoel D Kuypers J Vanwalleghem 2004 Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study Kidney Int 65 1842 9
27. S Tang JC Leung LY Chan YH Lui CS Tang CH Kan 2005 Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy Kidney Int 68 802 12
28. G Frisch J Lin J Rosenstock G Markowitz V D'Agati J Radhakrishnan 2005 Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial Nephrol Dial Transplant 20 2139 45
29. U Schöll U Wastl T Risler N Braun B Grabensee P Heering 1999 The "point of no return" and the rate of progression in the natural history of IgA nephritis Clin Nephrol 52 285 92
30. Y Kobayashi K Fujii Y Hiki S Tateno 1986 Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases Q J Med 61 935 43
31. Y Kobayashi Y Hiki T Kokubo AY Horii S Tateno 1996 Steroid therapy during the early stage of progressive IgA nephropathy: a 10-year follow-up study Nephron 72 237 42